Mendel Capital Management LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mendel Capital Management LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,149 shares of the healthcare conglomerate’s stock after buying an additional 33 shares during the quarter. Mendel Capital Management LLC’s holdings in UnitedHealth Group were worth $672,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in shares of UnitedHealth Group by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after buying an additional 35,533 shares in the last quarter. International Assets Investment Management LLC increased its stake in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. increased its stake in shares of UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after purchasing an additional 21,149 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on UNH shares. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Morgan Stanley reduced their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $592.23 on Monday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market capitalization of $545.02 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The firm has a 50 day moving average of $582.84 and a 200 day moving average of $549.98.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm earned $6.56 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.